Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine

Neoplasma

Volumn 46, Issue 3, 1999, Pages 196-200

  Chang, K H ^a   Chen, M L ^b   Chen, H C ^a   Huang, Y W ^b   Wu, T Y ^b   Chen, Y J ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Radiosensitivity; Tetrandrine; U138MG

Indexed keywords

TETRANDRINE;

APOPTOSIS; ARTICLE; CANCER CELL; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID SOLUBILITY; MONONUCLEAR CELL; PROGNOSIS; RADIATION DOSE; RADIOSENSITIVITY; TUMOR VOLUME;

EID: 0032786803     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. BIGNER, D.D., BIGNER, S.H., PONTEN, J., WESTERMARK, B., MAHALEY, M.S., RUOSLAHTI, E., HERSCHMAN, H., ENG, L.F., WIKSTRAND, C.J.: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropath. Exp. Neur., 40, 1981, 201-229.
2. CHEN, K.K., CHEN, A.L.: The alkaloids of han-fang-chi. J. Biol. Chem., 109, 1935, 681-685.
3. CHEN, Y.J., TU, M.L., KUO H.C., CHANG, K.H., LAI, Y.L., CHUNG, C.H., CHEN, M.L.: Protective effect of tetrandrine on normal human mononuclear cells against ionizing irradiation. Biol. Pharm. Bull., 20, 1997, 1160-1164.
4. DAI, G.Z., ZENG, B., ZHANG, Y.L., LU, Y.X.: Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia. J. Cardiovasc. Dis., 14, 1986, 324-326.
5. HE, Q.Y., JIANG, B., ZHANG, H.Q., XUE, S.B.: Reversal of doxorubicin resistance in Chinese hamster ovary cell line. Acta Pharmacol. Sin., 13, 1992, 416-419.
6. JETT, J.: Mathematical analysis of DNA histogram from asynchronous and synchronous cell populations. In: Pulse Cytophotometry. Ed.: Lutz, D. Brussels, European Press 1978, 93-102.
7. JIN, H.: A study on the inhibition effect of tetrandrine on the pingyangmycinum induced pulmonary fibrosis. Chinese J. Tuber. Respir. Dis., 14, 1991, 359-361.
8. KONDO, Y., TAKANO, F., HOJO, H.: Inhibitory effect of bisbenylisoquinoline alkaloids on nitric oxide production in activated macrophages. Biochem. Pharmacol., 46, 1993, 1887-1892.
9. LAI, Y.L., CHEN, Y.J., WU, T.Y., WANG, S.Y., CHANG, K.H., CHUNG, C.H., CHEN, M.L.: Induction of apoptosis in human leukemic U937 cells by tetrandrine. Anti-cancer Drug, 9, 1998, 77-81.
10. LOEFFLER, J.S., ALEXANDER, E III, SHEA, W.M. ET AL.: Radiosurgery as part of the initial management of patients with malignant gliomas. J. Clin. Oncol., 10, 1992, 1379-1385.
11. MILLER, S.A., DYKES, D.D., POLESKY, H.E: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1988, 1215-1221.
12. SALAZAR, O., RUBIN, P., FELDSTEIN, M., PIZZUTIELLO, R.: High dose radiation therapy in the treatment of malignant gliomas: Final report. Int. J. Radiat. Oncol. Biol. Phys., 5, 1979, 1733-1740.
13. SEOW, W.K., FERRANTE, A., SUMMORS, A., THONG, Y.H.: Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor. Life Sci., 53, 1992, PL453-458.
14. THE, B.S., CHEN, P., LAVIN, M.F., SEOW, W.K., THONG, Y.H.: Demonstration of the induction of apoptosis (programmed cell death) by tetrandrine, a novel anti-inflammatory agent. Int. J. Immunopharmacol., 13, 1991, 1117-1126.
15. YE, L., SUN, A., LI, L., CAO, X., YE, W.: Reversal of adriamycin or vinblastine resistance by tetrandrine in human cancer cells in vitro. J. Chin. Materia Med., 21, 1996, 369-371.
16. Yu, S.L.: Cardiothermographic study of the effects of tetrandrine on experimental myocardial ischemia and infarction. Chinese Med. J., 66, 1986, 29-31.
17. ZENG, F.D., SHAW, D.H., OGILVIE, R.I.: Kinetic disposition and hemodynamic effects of tetrandrine in anesthetized dogs. J. Cardiovasc. Pharm., 7, 1985, 1034-1039.
18. ZERNIG, D.: Clinical future for calcium antagonists looks more promising. Trends Pharmacol., 12, 1991, 439-442.